116 related articles for article (PubMed ID: 8633253)
1. Role of chemotherapy for advanced colorectal cancer: new opportunities.
Bleiberg H
Semin Oncol; 1996 Feb; 23(1 Suppl 3):42-50. PubMed ID: 8633253
[TBL] [Abstract][Full Text] [Related]
2. [Recent advance in chemotherapy for advanced colorectal cancer].
Aiba K
Gan To Kagaku Ryoho; 1996 Apr; 23(5):535-48. PubMed ID: 8678510
[TBL] [Abstract][Full Text] [Related]
3. [Combination of 5-Fluorouracil and folinic acid--is it still the standard therapy for advanced colorectal carcinoma?].
Carnaghi C; Zucali P; Garassino I
Tumori; 2000; 86(5 Suppl 2):S19-25. PubMed ID: 11195298
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
[TBL] [Abstract][Full Text] [Related]
5. Review of the role of CPT-11 in the treatment of colorectal cancer.
Rougier P; Mitry E
Clin Colorectal Cancer; 2001 Aug; 1(2):87-94. PubMed ID: 12445366
[TBL] [Abstract][Full Text] [Related]
6. New drugs in the treatment of colorectal carcinoma.
Punt CJ
Cancer; 1998 Aug; 83(4):679-89. PubMed ID: 9708931
[TBL] [Abstract][Full Text] [Related]
7. Treatment of colorectal cancer metastasis: the role of chemotherapy.
Xiong HQ; Ajani JA
Cancer Metastasis Rev; 2004; 23(1-2):145-63. PubMed ID: 15000155
[TBL] [Abstract][Full Text] [Related]
8. The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer.
Khayat D; Gil-Delgado M; Antoine EC; Nizri D; Bastian G
Oncology (Williston Park); 2001 Apr; 15(4):415-29; discussion 429-30, 433-4. PubMed ID: 11346931
[TBL] [Abstract][Full Text] [Related]
9. CPT-11 (irinotecan) and 5-fluorouracil: a promising combination for therapy of colorectal cancer.
Saltz L; Shimada Y; Khayat D
Eur J Cancer; 1996; 32A Suppl 3():S24-31. PubMed ID: 8943662
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerase I inhibitors in the treatment of colorectal cancer.
Rothenberg ML; Blanke CD
Semin Oncol; 1999 Dec; 26(6):632-9. PubMed ID: 10606256
[TBL] [Abstract][Full Text] [Related]
11. Therapy for advanced colorectal cancer.
Benson AB
Semin Oncol; 1998 Oct; 25(5 Suppl 11):2-11. PubMed ID: 9786311
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of metastatic colorectal cancer.
Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
[TBL] [Abstract][Full Text] [Related]
13. Current status of colorectal cancer: CPT-11 (irinotecan), a therapeutic innovation.
Cunningham D
Eur J Cancer; 1996; 32A Suppl 3():S1-8. PubMed ID: 8943658
[TBL] [Abstract][Full Text] [Related]
14. Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer.
Fioravanti A; Canu B; Alì G; Orlandi P; Allegrini G; Di Desidero T; Emmenegger U; Fontanini G; Danesi R; Del Tacca M; Falcone A; Bocci G
Eur J Pharmacol; 2009 Oct; 619(1-3):8-14. PubMed ID: 19695243
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin: a new therapeutic option in colorectal cancer.
Cvitkovic E; Bekradda M
Semin Oncol; 1999 Dec; 26(6):647-62. PubMed ID: 10606258
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin plus 5-fluorouracil: clinical experience in patients with advanced colorectal cancer.
Bleiberg H; de Gramont A
Semin Oncol; 1998 Apr; 25(2 Suppl 5):32-9. PubMed ID: 9609106
[TBL] [Abstract][Full Text] [Related]
17. [Standard therapy of CPT-11 for colorectal cancer].
Saitoh S; Sakata Y
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1345-51. PubMed ID: 11681240
[TBL] [Abstract][Full Text] [Related]
18. Topoisomerase-I, thymidylate synthase primary tumour expression and clinical efficacy of 5-FU/CPT-11 chemotherapy in advanced colorectal cancer patients.
Paradiso A; Xu J; Mangia A; Chiriatti A; Simone G; Zito A; Montemurro S; Giuliani F; Maiello E; Colucci G
Int J Cancer; 2004 Aug; 111(2):252-8. PubMed ID: 15197779
[TBL] [Abstract][Full Text] [Related]
19. CPT-11 in gastrointestinal cancer.
Bleiberg H
Eur J Cancer; 1999 Mar; 35(3):371-9. PubMed ID: 10448285
[TBL] [Abstract][Full Text] [Related]
20. CPT-11: an original spectrum of clinical activity.
Rothenberg ML
Semin Oncol; 1996 Feb; 23(1 Suppl 3):21-6. PubMed ID: 8633249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
